Coated stents for the prevention of restenosis: Part I.
Babapulle
Mohan N
MN
Division of Cardiology, Montreal General Hospital/McGill University, Montreal, Quebec, Canada.
Eisenberg
Mark J
MJ
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects; D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D020099:Coated Materials, Biocompatible / Q000627:therapeutic use*; D023903:Coronary Restenosis / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*; D003692:Delayed-Action Preparations / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004343:Drug Implants / Q000627:therapeutic use; D006801:Humans; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D015607:Stents / Q000592:standards / Q000639:trends; D016896:Treatment Outcome
D000305:Adrenal Cortex Hormones; D000925:Anticoagulants; D000970:Antineoplastic Agents; D020099:Coated Materials, Biocompatible; D003692:Delayed-Action Preparations; D004343:Drug Implants